AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) is among the best fundamentally strong penny stocks to buy right now. Jason McCarthy, an analyst at Maxim Group, initiated coverage on AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) with a ‘Buy’ rating and $6.00 price target. This implies a potential upside of nearly 133%. Earlier this month, AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) shared the positive progress from its Ampligen clinical program in pancreatic cancer at the 5th Annual Marie Sklodowska-Curie Symposium on Cancer ...